Literature DB >> 18445136

Partial inhibition of complex I activity increases Ca-independent glutamate release rates from depolarized synaptosomes.

Seán M Kilbride1, Jayne E Telford, Keith F Tipton, Gavin P Davey.   

Abstract

Mitochondria have been implicated in the pathogenesis of several neurodegenerative disorders and, in particular, complex I (NADH:ubiquinone oxidoreductase, EC 1.6.5.3) activity has been shown to be partially reduced in postmortem studies of the substantia nigra of Parkinson's disease patients. The present study examines the effect of partial inhibition of complex I activity on glutamate release from rat brain synaptosomes. Following a 40% inhibition of complex I activity with rotenone, it was found that Ca(2+)-independent release of glutamate increased from synaptosomes depolarized with 4-aminopyridine. Highest rates of glutamate release were found to occur between 60-90% complex I inhibition. A similar pattern of increase was shown to occur in synaptosomes depolarized with KCl. The increase in glutamate release was found to correlate to a significant decrease in ATP. Inhibition of complex I activity by 40% was also shown to cause a significant collapse in mitochondrial membrane potential (Deltapsi(m)). These results suggest that partial inhibition of complex I activity in in situ mitochondria is sufficient to significantly increase release of glutamate from the pre-synaptic nerve terminal. The relevance of these results in the context of excitotoxicity and the pathogenesis of neurodegenerative disorders is discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18445136     DOI: 10.1111/j.1471-4159.2008.05441.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

1.  Mitochondrial CB₁ receptors regulate neuronal energy metabolism.

Authors:  Giovanni Bénard; Federico Massa; Nagore Puente; Joana Lourenço; Luigi Bellocchio; Edgar Soria-Gómez; Isabel Matias; Anna Delamarre; Mathilde Metna-Laurent; Astrid Cannich; Etienne Hebert-Chatelain; Christophe Mulle; Silvia Ortega-Gutiérrez; Mar Martín-Fontecha; Matthias Klugmann; Stephan Guggenhuber; Beat Lutz; Jürg Gertsch; Francis Chaouloff; María Luz López-Rodríguez; Pedro Grandes; Rodrigue Rossignol; Giovanni Marsicano
Journal:  Nat Neurosci       Date:  2012-03-04       Impact factor: 24.884

2.  Complex I Controls Mitochondrial and Plasma Membrane Potentials in Nerve Terminals.

Authors:  Seán M Kilbride; Jayne E Telford; Gavin P Davey
Journal:  Neurochem Res       Date:  2020-03-04       Impact factor: 3.996

3.  Co-administration of betulinic acid and methamphetamine causes toxicity to dopaminergic and serotonergic nerve terminals in the striatum of late adolescent rats.

Authors:  Bryan Killinger; Mrudang Shah; Anna Moszczynska
Journal:  J Neurochem       Date:  2013-12-03       Impact factor: 5.372

Review 4.  Toxin models of mitochondrial dysfunction in Parkinson's disease.

Authors:  Terina N Martinez; J Timothy Greenamyre
Journal:  Antioxid Redox Signal       Date:  2011-07-12       Impact factor: 8.401

5.  Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes.

Authors:  Vittorio Calabrese; Carolin Cornelius; Anna Maria Giuffrida Stella; Edward J Calabrese
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

6.  The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals.

Authors:  Khanh T Nguyen; Luis E García-Chacón; John N Barrett; Ellen F Barrett; Gavriel David
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

7.  Decylubiquinone increases mitochondrial function in synaptosomes.

Authors:  Jayne E Telford; Seán M Kilbride; Gavin P Davey
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

8.  Treatment of mitochondrial disorders.

Authors:  Sreenivas Avula; Sumit Parikh; Scott Demarest; Jonathan Kurz; Andrea Gropman
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

9.  Complex I is rate-limiting for oxygen consumption in the nerve terminal.

Authors:  Jayne E Telford; Seán M Kilbride; Gavin P Davey
Journal:  J Biol Chem       Date:  2009-02-04       Impact factor: 5.157

10.  Protein SUMOylation modulates calcium influx and glutamate release from presynaptic terminals.

Authors:  Marco Feligioni; Atsushi Nishimune; Jeremy M Henley
Journal:  Eur J Neurosci       Date:  2009-04       Impact factor: 3.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.